Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy of alcoholism – an update on approved and off-label medications
Michael Soyka, Christian A. Müller
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1187-1199
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Alcohol and Opioid Use, Co‐Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review
Katie Witkiewitz, Kevin E. Vowles
Alcoholism Clinical and Experimental Research (2018) Vol. 42, Iss. 3, pp. 478-488
Open Access | Times Cited: 203
A potential role for the gut microbiome in substance use disorders
Katherine Meckel, Drew D. Kiraly
Psychopharmacology (2019) Vol. 236, Iss. 5, pp. 1513-1530
Open Access | Times Cited: 127
Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Justin Knox, Deborah S. Hasin, Farren R R Larson, et al.
The Lancet Psychiatry (2019) Vol. 6, Iss. 12, pp. 1054-1067
Open Access | Times Cited: 114
Noradrenergic targets for the treatment of alcohol use disorder
Carolina L. Haass‐Koffler, Robert M. Swift, Lorenzo Leggio
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1625-1634
Open Access | Times Cited: 109
Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review
Shao-Cheng Wang, Yuan‐Chuan Chen, Shaw-Ji Chen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6413-6413
Open Access | Times Cited: 105
Neuroimmune mechanisms of psychostimulant and opioid use disorders
Rebecca S. Hofford, Scott J. Russo, Drew D. Kiraly
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2562-2573
Open Access | Times Cited: 84
Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
Pablo Berríos‐Cárcamo, Mauricio Quezada, Marı́a Elena Quintanilla, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 830-830
Open Access | Times Cited: 71
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Alcohol Use Disorder: Neurobiology and Therapeutics
Waisley Yang, Rohit Singla, Oshin Maheshwari, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1192-1192
Open Access | Times Cited: 42
Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report
Thitiporn Supasitthumrong, Blanca Bolea-Alamañac, Selim Asmer, et al.
British Journal of Clinical Pharmacology (2018) Vol. 85, Iss. 4, pp. 690-703
Open Access | Times Cited: 70
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
Jeremiah Fairbanks, Audrey Umbreit, Bhanu Prakash Kolla, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1964-1977
Open Access | Times Cited: 58
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
Julia de Ternay, Mickaël Naassïla, Mikaïl Nourredine, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 47
Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum
Hiroshi Mitoma, Mario Manto, Aasef G. Shaikh
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 16, pp. 8678-8678
Open Access | Times Cited: 36
New steps for treating alcohol use disorder
Erin J. Campbell, Andrew J. Lawrence, Christina J. Perry
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1759-1773
Closed Access | Times Cited: 43
Ketamine normalizes binge drinking-induced defects in glutamatergic synaptic transmission and ethanol drinking behavior in female but not male mice
Nicole A. Crowley, Sarah N. Magee, Mengyang Feng, et al.
Neuropharmacology (2019) Vol. 149, pp. 35-44
Open Access | Times Cited: 35
It’s more than just interoception: The insular cortex involvement in alcohol use disorder
Erin J. Campbell, Andrew J. Lawrence
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1644-1651
Open Access | Times Cited: 31
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Roles of Oxidative Stress and Autophagy in Alcohol-Mediated Brain Damage
Leon Ruiter-Lopez, Mohammed Abdul Sattar Khan, Xin Wang, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 302-302
Open Access
Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes
Kethely Lima Marques, Victor Rodrigues, Cassiana T. N. Balduci, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Pharmacogenetics of alcohol use disorder treatments: an update
Emily E. Hartwell, Henry R. Kranzler
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 7, pp. 553-564
Open Access | Times Cited: 29
Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years
M. Carmen Blanco-Gandía, Marta Rodrı́guez-Arias
European Journal of Pharmacology (2018) Vol. 836, pp. 89-101
Closed Access | Times Cited: 28
The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review
Amanda Brunchmann, Morgane Thomsen, Anders Fink‐Jensen
Physiology & Behavior (2019) Vol. 206, pp. 232-242
Open Access | Times Cited: 26
Alcohol brief intervention, specialty treatment and drinking outcomes at 12 months: Results from a systematic alcohol screening and brief intervention initiative in adult primary care
W. Felicia, Sujaya Parthasarathy, Vanessa A. Palzes, et al.
Drug and Alcohol Dependence (2022) Vol. 235, pp. 109458-109458
Open Access | Times Cited: 14
Ethanol-Induced Suppression of G Protein–Gated Inwardly Rectifying K+–Dependent Signaling in the Basal Amygdala
Ezequiel Marrón Fernández de Velasco, Megan E. Tipps, Bushra Haider, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 11, pp. 863-874
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top